BioLife Solutions, Inc. (BLFS)Rep. Christopher L. Jacobs (NY27) disclosed a sale $1K–$15K
Rep. Christopher L. Jacobs (NY27) disclosed a sale of BioLife Solutions, Inc. in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 39 days
- Disclosure lag
- Traded
- Dec 12, 2022
- Disclosed
- Jan 20, 2023
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 8, 2022CongressDisclosed purchase of BLFS — reported range $1,001 - $15,000
- Dec 12, 2022 · this disclosureCongressDisclosed sale of BLFS — reported range $1,001 - $15,000
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for BioLife Solutions, Inc.
For BioLife Solutions, Inc., OQRO holds 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BLFS page.
Other recent filings by Rep. Christopher L. Jacobs (NY27)
- House Clerk periodic transaction report at Anavex Life Sciences (AVXL)Jan 20, 2023
- House Clerk periodic transaction report at Archrock, Inc. (AROC)Jan 20, 2023
- House Clerk periodic transaction report at Bank of America (BAC)Jan 20, 2023
- House Clerk periodic transaction report at Berkshire Hathaway (BRK.B)Jan 20, 2023
- House Clerk periodic transaction report at Borr Drilling (BORR)Jan 20, 2023
The full history of Rep. Christopher L. Jacobs (NY27) is on the profile page.
How this filing works
Other disclosures at BioLife Solutions, Inc.
- USAspending.gov award recordAug 31, 2026
- SEC Form 4May 21, 2026
- SEC Form 4May 21, 2026
- SEC Form 4May 21, 2026
- SEC Form 4Mar 31, 2026
- SEC Form 4Mar 9, 2026
Everything OQRO holds on this company is on its BLFS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data